Imperial Incubator, the incubator for Imperial College London, surpasses $1bn in external funding for its 60 startups within a decade.
Imperial Incubator, the incubator for Imperial College London, has announced that its 60 companies have collectively raised £750m ($1.2bn) over the past decade.
The news comes as four spinouts prepare to leave the nest. Image recognition specialist Cortexica, allergy testing firm Microtest DX, clean cold tech firm Dearman, and lung disease drug discovery firm RespiVert are all moving into larger facilities, with Microtest moving to Imperial’s new facilities at the White City Campus.
The incubator, which is a part of ICL’s technology transfer office Imperial Innovations, is a 24,000 foot facility on campus with 12 labs and 22 offices.
David Gann, vice president for development and innovation) at Imperial College London, said: “It is extraordinary to see how much value has been created in the Imperial Incubator. The products conceived, jobs created and investment attracted are great news for Imperial, London and the world. The Imperial Incubator community is marked by its creative, collaborative and courageous nature. It is a special moment when a start-up or spinout graduates from its original institution. We are proud of our graduating firms, inspired by their leadership and excited to see what they do next.”
